North America Medical Marijuana Market Size & Outlook
North America medical marijuana market, 2018-2030 (US$M)
Related Markets
North America medical marijuana market highlights
- The North America medical marijuana market generated a revenue of USD 12,258.3 million in 2023.
- The market is expected to grow at a CAGR of 13.3% from 2024 to 2030.
- In terms of segment, oil and tinctures was the largest revenue generating product in 2023.
- Oil and Tinctures is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 12,258.3 million |
| Market revenue in 2030 | USD 29,357.5 million |
| Growth rate | 13.3% (CAGR from 2023 to 2030) |
| Largest segment | Oil and tinctures |
| Fastest growing segment | Oil and Tinctures |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Flower, Oil and Tinctures |
| Key market players worldwide | Tilray Brands Inc, Aurora Cannabis Inc, Canopy Growth Corp, Aphria Inc, Wayland Group Corp, Aurora Cannabis, GW Pharmaceuticals, Cannabis Sativa Inc, Medical Marijuana Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 73.9% of the global medical marijuana market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 7,402.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Medical Marijuana Market Scope
Medical Marijuana Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America medical marijuana market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical marijuana market will help companies and investors design strategic landscapes.
Oil and tinctures was the largest segment with a revenue share of 54.72% in 2023. Horizon Databook has segmented the North America medical marijuana market based on flower, oil and tinctures covering the revenue growth of each sub-segment from 2018 to 2030.
- North America Medical Marijuana Product Outlook (Revenue, USD Million, 2018-2030)
- Flower
- Oil and Tinctures
- North America Medical Marijuana Application Outlook (Revenue, USD Million, 2018-2030)
- Cancer
- Chronic Pain
- Depression and Anxiety
- Arthritis
- Diabetes
- Glaucoma
- Migraines
- Epilepsy
- Multiple Sclerosis
- AIDS
- Amyotrophic Lateral Sclerosis
- Alzheimers's
- Post Traumatic Stress Disorder (PTSD)
- Parkinson's
- Tourettes
- Others
Reasons to subscribe to North America medical marijuana market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America medical marijuana market databook
-
Our clientele includes a mix of medical marijuana market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America medical marijuana market , including forecasts for subscribers. This continent databook contains high-level insights into North America medical marijuana market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America medical marijuana market size, by country, 2018-2030 (US$M)
North America Medical Marijuana Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
